CLINICAL_TRIALS
trial_result
· 2019-05-06
Clinical Trial Update: Diabetes Prevention - Immune Tolerance [Phase 2]
Summary
Phase 2 trial update on an immune tolerance strategy for diabetes prevention in individuals with prediabetes and type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lund University | Conditions: Prediabetes, Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2019-05-06